Roswell Park Comprehensive Cancer Center — Buffalo, New York

Roswell Park Comprehensive Cancer Center is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Roswell Park Comprehensive Cancer Center has participated in 152 clinical trials with 94 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Platinum-resistant Ovarian Cancer, Endometrial Cancer.

Sponsors: Constellation Pharmaceuticals, Nurix Therapeutics, Inc., Celularity Incorporated.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Comprehensive Cancer Center?

Roswell Park Comprehensive Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Comprehensive Cancer Center conducted?

Roswell Park Comprehensive Cancer Center has 152 clinical trials on record, with 94 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Platinum-resistant Ovarian Cancer, Endometrial Cancer.

Is Roswell Park Comprehensive Cancer Center accredited by Crixeo Health?

Roswell Park Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.